现代肿瘤医学
現代腫瘤醫學
현대종류의학
Journal of Modern Oncology
2015年
24期
3638-3642
,共5页
陈真%刘媛媛%谢新平%姚品芳
陳真%劉媛媛%謝新平%姚品芳
진진%류원원%사신평%요품방
流式细胞术%免疫功能%T 淋巴细胞亚群%NK 细胞
流式細胞術%免疫功能%T 淋巴細胞亞群%NK 細胞
류식세포술%면역공능%T 림파세포아군%NK 세포
FCM%immunologic function%T lymphocyte subsets%NK cells
目的:研究妇科肿瘤患者的免疫功能变化情况,观察机体免疫功能与患者年龄、临床分期、治疗方式等因素的关系。方法:运用流式细胞术对151例患者外周血 T 淋巴细胞亚群及 NK 细胞进行检测。结果:与良性组比较,恶性肿瘤组 CD3+下降、CD4+下降极显著(P <0.01),CD4+/CD8+下降显著(P <0.05),CD8+则略有升高;恶性肿瘤组 CD4+、CD4+/CD8+表现出随临床分期提高逐渐降低的趋势,CD8+则反之。其中Ⅲ-Ⅳ期 CD8+、CD4+/CD8+较 I 期存在极显著性差异(P <0.01);与未转移组比较,已转移组 CD3+下降、CD4+下降显著(P <0.05),CD4+/CD8+下降极显著(P <0.01),CD8+升高;术后组 CD3+、CD4+、CD4+/CD8+较未治疗组升高,CD8+下降,并且 CD4+/CD8+升高显著(P <0.05);术后组 CD4+、CD4+/CD8+较放化疗组升高、CD8+下降,差异均极显著(P <0.01);放化疗组 CD4+、CD8+、CD4+/CD8+与未治疗组比较差异具有统计学意义(P <0.05)。结论:妇科肿瘤患者的免疫功能受到不同程度的抑制,这种抑制与患者年龄、病情进展存在一定的相关性。在肿瘤治疗中解除瘤负荷和保护机体的免疫功能具有同等重要的意义。
目的:研究婦科腫瘤患者的免疫功能變化情況,觀察機體免疫功能與患者年齡、臨床分期、治療方式等因素的關繫。方法:運用流式細胞術對151例患者外週血 T 淋巴細胞亞群及 NK 細胞進行檢測。結果:與良性組比較,噁性腫瘤組 CD3+下降、CD4+下降極顯著(P <0.01),CD4+/CD8+下降顯著(P <0.05),CD8+則略有升高;噁性腫瘤組 CD4+、CD4+/CD8+錶現齣隨臨床分期提高逐漸降低的趨勢,CD8+則反之。其中Ⅲ-Ⅳ期 CD8+、CD4+/CD8+較 I 期存在極顯著性差異(P <0.01);與未轉移組比較,已轉移組 CD3+下降、CD4+下降顯著(P <0.05),CD4+/CD8+下降極顯著(P <0.01),CD8+升高;術後組 CD3+、CD4+、CD4+/CD8+較未治療組升高,CD8+下降,併且 CD4+/CD8+升高顯著(P <0.05);術後組 CD4+、CD4+/CD8+較放化療組升高、CD8+下降,差異均極顯著(P <0.01);放化療組 CD4+、CD8+、CD4+/CD8+與未治療組比較差異具有統計學意義(P <0.05)。結論:婦科腫瘤患者的免疫功能受到不同程度的抑製,這種抑製與患者年齡、病情進展存在一定的相關性。在腫瘤治療中解除瘤負荷和保護機體的免疫功能具有同等重要的意義。
목적:연구부과종류환자적면역공능변화정황,관찰궤체면역공능여환자년령、림상분기、치료방식등인소적관계。방법:운용류식세포술대151례환자외주혈 T 림파세포아군급 NK 세포진행검측。결과:여량성조비교,악성종류조 CD3+하강、CD4+하강겁현저(P <0.01),CD4+/CD8+하강현저(P <0.05),CD8+칙략유승고;악성종류조 CD4+、CD4+/CD8+표현출수림상분기제고축점강저적추세,CD8+칙반지。기중Ⅲ-Ⅳ기 CD8+、CD4+/CD8+교 I 기존재겁현저성차이(P <0.01);여미전이조비교,이전이조 CD3+하강、CD4+하강현저(P <0.05),CD4+/CD8+하강겁현저(P <0.01),CD8+승고;술후조 CD3+、CD4+、CD4+/CD8+교미치료조승고,CD8+하강,병차 CD4+/CD8+승고현저(P <0.05);술후조 CD4+、CD4+/CD8+교방화료조승고、CD8+하강,차이균겁현저(P <0.01);방화료조 CD4+、CD8+、CD4+/CD8+여미치료조비교차이구유통계학의의(P <0.05)。결론:부과종류환자적면역공능수도불동정도적억제,저충억제여환자년령、병정진전존재일정적상관성。재종류치료중해제류부하화보호궤체적면역공능구유동등중요적의의。
Objective:To evaluate the changes of the immune function of gynecology tumor,and observe the rela-tionship between the immune function and age,TNM,treatment,etc.Methods:Peripheral blood T lymphocyte subsets and NK cells of 151 patients were detected by flow cytometry(FCM).Results:Lowers CD3 +,CD4 +(P <0.01)and CD4 +/CD8 + ratio(P <0.05)were detected in blood samples from the malignancies than that from the benign,CD8 +were slightly elevated.CD4 + and CD4 +/CD8 + ratio from the malignancies were negatively correlated with TNM stage,the CD8 + were reverse.There were significant differences of CD8 + and CD4 +/CD8 + ratio(P <0.01)betweenⅢ -Ⅳ period and I period.Compared with the no -metastasis group,CD3 +,CD4 + and CD4 +/CD8 + ratio were de-creased,CD8 + were elevated,which from the transfer group,the differences from CD4 + and CD8 + were significant(P<0.05),and the one from CD4 +/CD8 + ratio was highly significant different(P <0.01).CD3 +,CD4 + and CD4 +/CD8 + ratio from operation group were higher in comparison with that in untreated group,CD8 + was lower,and CD4 +/CD8 + ratio was significantly higher(P <0.05).CD4 + and CD4 +/CD8 + ratio from operation group were significantly higher(P <0.01)than that in chemoradiotherapy group,and CD8 + was significantly lower(P <0.01).The differ-ence of CD4 +,CD8 + and CD4 + /CD8 + ratio between chemoradiotherapy group and untreated group was differ-ent(P <0.05).Conclusion:The immune function in gynecology tumor patients was correlate with patients'age,and disease progression,was inhibited with different degrees.Removing the tumor was as importent as protecting the im-mune function.